| 1 |
35168478 | Structural exploration of selected C6 and C7-substituted coumarin isomers as selective MAO-B inhibitors. | 2022 Feb 15 |
4 |
| 2 |
35195417 | Probing Fluorinated Motifs onto Dual AChE-MAO B Inhibitors: Rational Design, Synthesis, Biological Evaluation, and Early-ADME Studies. | 2022 Mar 10 |
1 |
| 3 |
35300078 | Dual Reversible Coumarin Inhibitors Mutually Bound to Monoamine Oxidase B and Acetylcholinesterase Crystal Structures. | 2022 Mar 10 |
2 |
| 4 |
33921982 | Coumarin-Chalcone Hybrids as Inhibitors of MAO-B: Biological Activity and In Silico Studies. | 2021 Apr 22 |
1 |
| 5 |
34879800 | Multi-Target Directed Ligands (MTDLs): Promising Coumarin Hybrids for Alzheimer's Disease. | 2021 |
1 |
| 6 |
32037726 | Coumarin-Rasagiline Hybrids as Potent and Selective hMAO-B Inhibitors, Antioxidants, and Neuroprotective Agents. | 2020 Mar 18 |
1 |
| 7 |
31325784 | Design, synthesis and biological evaluation of hydroxypyridinone-coumarin hybrids as multimodal monoamine oxidase B inhibitors and iron chelates against Alzheimer's disease. | 2019 Oct 15 |
2 |
| 8 |
29390885 | Multi-targeted directed ligands for Alzheimer's disease: design of novel lead coumarin conjugates. | 2018 Mar |
2 |
| 9 |
29552556 | Structure-Activity Relationship Analysis of 3-Phenylcoumarin-Based Monoamine Oxidase B Inhibitors. | 2018 |
1 |
| 10 |
27744252 | Synthesis and evaluation of 7-substituted coumarin derivatives as multimodal monoamine oxidase-B and cholinesterase inhibitors for the treatment of Alzheimer's disease. | 2017 Jan 5 |
2 |
| 11 |
28291352 | Understanding the Molecular Determinant of Reversible Human Monoamine Oxidase B Inhibitors Containing 2H-Chromen-2-One Core: Structure-Based and Ligand-Based Derived Three-Dimensional Quantitative Structure-Activity Relationships Predictive Models. | 2017 Apr 24 |
1 |
| 12 |
28797881 | Synthesis and structure-activity relationship study of novel 3-heteroarylcoumarins based on pyridazine scaffold as selective MAO-B inhibitors. | 2017 Oct 20 |
2 |
| 13 |
26917219 | Design, synthesis and biological evaluation of novel donepezil-coumarin hybrids as multi-target agents for the treatment of Alzheimer's disease. | 2016 Apr 1 |
1 |
| 14 |
27347731 | Exploring Basic Tail Modifications of Coumarin-Based Dual Acetylcholinesterase-Monoamine Oxidase B Inhibitors: Identification of Water-Soluble, Brain-Permeant Neuroprotective Multitarget Agents. | 2016 Jul 28 |
1 |
| 15 |
25812965 | Multi-target tacrine-coumarin hybrids: cholinesterase and monoamine oxidase B inhibition properties against Alzheimer's disease. | 2015 May 5 |
1 |
| 16 |
25857233 | Inhibition effects of Vernonia cinerea active compounds against cytochrome P450 2A6 and human monoamine oxidases, possible targets for reduction of tobacco dependence. | 2015 Apr |
1 |
| 17 |
24934993 | Coumarin hybrids as novel therapeutic agents. | 2014 Aug 1 |
1 |
| 18 |
23589499 | MAO inhibitory activity of 2-arylbenzofurans versus 3-arylcoumarins: synthesis, in vitro study, and docking calculations. | 2013 Jun |
1 |
| 19 |
24012182 | Inhibition of monoamine oxidase by 3,4-dihydro-2(1H)-quinolinone derivatives. | 2013 Oct 15 |
2 |
| 20 |
24231308 | Fine molecular tuning at position 4 of 2H-chromen-2-one derivatives in the search of potent and selective monoamine oxidase B inhibitors. | 2013 |
2 |
| 21 |
21684743 | MAO inhibitory activity modulation: 3-Phenylcoumarins versus 3-benzoylcoumarins. | 2011 Jul 15 |
1 |
| 22 |
17915852 | Structures of human monoamine oxidase B complexes with selective noncovalent inhibitors: safinamide and coumarin analogs. | 2007 Nov 15 |
3 |
| 23 |
17034132 | Impact of species-dependent differences on screening, design, and development of MAO B inhibitors. | 2006 Oct 19 |
1 |